Hey Jane Company Profile

Background

Hey Jane is a New York City-based healthcare company founded in 2020 by Gaby Izarra, Kiki Freedman, and Dr. Kate Shaw. The company specializes in providing telemedicine services for reproductive and sexual health, with a primary focus on offering safe, private, and accessible medication abortion care. Hey Jane's mission is to empower individuals by delivering discreet and judgment-free healthcare services through a virtual platform, thereby eliminating traditional barriers to access.

Key Strategic Focus

Hey Jane's strategic objectives center on expanding access to reproductive healthcare through telemedicine. The company specializes in medication abortion services, utilizing FDA-approved medications such as mifepristone and misoprostol. Their virtual platform enables patients to consult with U.S.-licensed providers and receive medications via mail, ensuring privacy and convenience. Hey Jane targets individuals seeking reproductive and sexual health services, particularly those in regions with limited access to in-person clinics.

Financials and Funding

Since its inception, Hey Jane has secured a total of $9.7 million in funding. In October 2022, the company raised $6.1 million from mission-aligned, female-founded funds, including Ulu Ventures and The Helm. This capital is intended to support the expansion of services to all 50 states and the introduction of treatments for conditions such as postpartum depression and anxiety.

Pipeline Development

Hey Jane has expanded its service offerings beyond medication abortion to include treatments for vaginal infections (such as urinary tract infections, bacterial vaginosis, and herpes), birth control, and emergency contraception. These services are currently available in 11 states, with plans for further expansion.

Technological Platform and Innovation

Hey Jane's proprietary telemedicine platform facilitates secure and confidential consultations between patients and healthcare providers via text, phone, or video. This platform ensures timely access to care, with consultations typically occurring within one business day. The company employs advanced data security measures to protect patient information and complies with all relevant healthcare regulations.

Leadership Team

Kiki Freedman, Co-Founder and CEO: Kiki Freedman co-founded Hey Jane in 2020, leveraging her background in technology and healthcare to address gaps in reproductive health access. Under her leadership, the company has expanded its services and geographic reach.

Gaby Izarra, Co-Founder and Head of Growth and Marketing: Gaby Izarra oversees the company's growth strategies and marketing initiatives, focusing on increasing awareness and adoption of Hey Jane's services.

Dr. Kate Shaw, Co-Founder: Dr. Shaw contributes her medical expertise to ensure the clinical quality and safety of Hey Jane's services.

Alyssa Wagner, DNP, RN, APRN, WHNP-BC, Medical Director: Alyssa Wagner leads the clinical team, bringing over 14 years of experience in reproductive and sexual health care. She is dedicated to increasing healthcare access and reducing stigma.

Leadership Changes

As of the latest available information, there have been no recent significant changes or appointments within Hey Jane's leadership team.

Competitor Profile

Market Insights and Dynamics

The telemedicine reproductive health market has experienced significant growth, driven by increasing demand for accessible and private healthcare solutions. The overturning of Roe v. Wade has further intensified the need for telehealth services, as many individuals seek alternatives to in-person clinics.

Competitor Analysis

Choix: A telehealth provider offering medication abortion services, similar to Hey Jane. Choix operates in multiple states and focuses on providing discreet and accessible care.

Just The Pill: Provides telemedicine abortion services, delivering medications by mail. The company emphasizes privacy and convenience for patients seeking abortion care.

Wisp: Offers a range of telehealth services, including birth control and treatment for sexually transmitted infections. While not exclusively focused on abortion care, Wisp competes in the broader reproductive health telemedicine market.

Strategic Collaborations and Partnerships

Hey Jane collaborates with various insurance providers, including Aetna, Anthem, Blue Cross Blue Shield, and Cigna Healthcare, to offer covered services to patients. The company also partners with abortion funds to assist patients in covering treatment costs, ensuring that financial barriers do not impede access to care.

Operational Insights

Hey Jane differentiates itself through its patient-centered approach, offering a comprehensive suite of reproductive and sexual health services via a secure telemedicine platform. The company's commitment to privacy, affordability, and rapid access to care positions it favorably in the competitive landscape. By accepting insurance and providing sliding-scale pricing, Hey Jane addresses financial accessibility, a critical factor in healthcare delivery.

Strategic Opportunities and Future Directions

Hey Jane aims to expand its services to all 50 states, addressing the growing demand for telemedicine reproductive health services. The company plans to introduce treatments for conditions such as postpartum depression and anxiety, broadening its scope within the reproductive health domain. Continued investment in technology and partnerships with insurance providers will be pivotal in achieving these objectives.